cardiovascular benefits of glp 1 agonists glucagon-like peptide-1 receptor Cardiovascular Protection with a Long-Acting
Description
Some studies showed that it can promote pancreatic intraepithelial neoplasia [40,41]
The literature indicates potential interactions between some disclosed ingredients and certain medications, particularly berberine with diabetes and blood pressure medications
Rizvi, A., Rizzo, M
The SOUL trial (NCT06659718) will investigate the effect of semaglutide on cardiovascular outcomes in patients with T2DM who have preexisting cardiovascular disease and/or CKD
OK provided financial support for the study
